University · founded 1919

Kettering University

Flint, United States · kettering.edu

Manage this page

Citations, last 5 years: 2 490
Works, last 5 years: 440
h-index: 112
Scientists listed: 28
Grants since 2016: 3 213

Grants received

2018–2023 · research · R01

Image-guided TRAIL-enhanced CAR T-cell immunotherapy

Vladimir Ponomarev · Kettering University · funded by National Institutes of Health

$565.6kCAR-T cell therapy research

2018–2020 · research · R21

Statistical Evaluation and Selection of Normalization Methods for microRNA Sequencing Data in Cancer Biomarker Studies

Li-Xuan Qin · Kettering University · funded by National Institutes of Health

$224.1kMicroRNA in disease regulation

2018–2023 · research · R01

Epigenetic mechanisms of transcriptional activation of a novel oncogenic ALK variant in cancer

Ping Chi · Kettering University · funded by National Institutes of Health

$498.7k

2018–2023 · research · R01

Defining mechanisms of resistance to hormonal therapy in breast cancer

Sarat Chandarlapaty · Kettering University · funded by National Institutes of Health

$410.8k

2018–2021 · research · R50

Exploiting tumor metabolism to optimize T cell therapy

Inna Serganova · Kettering University · funded by National Institutes of Health

$91.1k

2018–2020 · fellowship · F99

The Role of Epigenetic Tumor Suppressors in Regulating Tumorigenesis and Tumor-Immune Crosstalk

Yuchen Xie · Kettering University · funded by National Institutes of Health

$46k

2018–2023 · research · R01

Image-guided irreversible electroporation directed CAR T-cell delivery to solid tumors

Prasad S. Adusumilli · Kettering University · funded by National Institutes of Health

$410.8kCAR-T cell therapy research

2018–2023 · cooperative agreement · U2C

Transition to Metastatic State: Lung Cancer, Pancreatic Cancer and Brain Metastasis

Christine A Iacobuzio-Donahue · Kettering University · funded by National Institutes of Health

$2.7M

2018–2022 · research · R01

Alloreactive and autoreactive immune-mediated mechanisms of impaired epithelial regeneration in the GI tract

Alan M Hanash · Kettering University · funded by National Institutes of Health

$630.7k

2018–2022 · research · R01

Assessment of sensory gating, attention, and executive control in breast cancer

Tim Alan Ahles · Kettering University · funded by National Institutes of Health

$637.9kCancer-related cognitive impairment studies

2018–2028 · research · R35

Mechanisms of DNA and RNA Transactions

Stewart H Shuman · Kettering University · funded by National Institutes of Health

$1.1M

2018–2023 · cooperative agreement · U2C

Transition to Metastatic State: Lung Cancer, Pancreatic Cancer and Brain Metastasis

Christine A Iacobuzio-Donahue · Kettering University · funded by National Institutes of Health

$2.7MBrain Metastases and Treatment

2018–2023 · grant · DP5

The role of chromosomal instability in tumor evolution

Samuel F Bakhoum · Kettering University · funded by National Institutes of Health

$449k

2018–2023 · research · R01

DOTA-based pre-targeting of alpha emitters

Sarah Marie Cheal · Kettering University · funded by National Institutes of Health

$726.2kRadiopharmaceutical Chemistry and Applications

2018–2025 · career development · K08

Adaptation and Pilot Feasibility of a Psychotherapy Intervention for Latinos with Advanced Cancer

Rosario Costas-Muniz · Kettering University · funded by National Institutes of Health

$180.3k

2018–2023 · research · R01

Image-guided irreversible electroporation directed CAR T-cell delivery to solid tumors

Prasad S. Adusumilli · Kettering University · funded by National Institutes of Health

$392.8kCAR-T cell therapy research

2018–2020 · research · R21

Responses to Genetic Risk Modifier Testing Among Women with BRCA1/2 Mutations

Jada Gabrielle Hamilton · Kettering University · funded by National Institutes of Health

$186.7kBRCA gene mutations in cancer

2018–2020 · career development · K08

Defining the Biological and Mechanistic Implications of XPO1 Mutations in Hematologic Malignancies

Justin Taylor · Kettering University · funded by National Institutes of Health

$31.4kNuclear Structure and Function

2018–2022 · research · R37

Obesity, chemotherapy dosing, and breast cancer outcomes

Elizabeth David Kantor · Kettering University · funded by National Institutes of Health

$632.3kCancer Risks and Factors

2018–2024 · research · R01

FOOD (Food to Overcome Outcomes Disparities)

Francesca M Gany · Kettering University · funded by National Institutes of Health

$662.6kFood Security and Health in Diverse Populations

2018–2021 · research · R21

Statistical Evaluation and Selection of Normalization Methods for microRNA Sequencing Data in Cancer Biomarker Studies

Li-Xuan Qin · Kettering University · funded by National Institutes of Health

$189.5kMicroRNA in disease regulation

2018–2025 · research · R35

Molecular Mechanisms of Drug Resistance in Primary Brain Tumors

Ingo K Mellinghoff · Kettering University · funded by National Institutes of Health

$582.9k

2018–2028 · research · R01

Characterizing the Mechanism of DPP8/9 Inhibitor-Induced Pyroptosis

Daniel Bachovchin · Kettering University · funded by National Institutes of Health

$523.8kInflammasome and immune disorders

2018–2023 · grant · DP5

The role of chromosomal instability in tumor evolution

Samuel F Bakhoum · Kettering University · funded by National Institutes of Health

$449k

2018–2023 · research · R01

Endothelial cells regulate immune reconstitution after hematopoietic stem cell transplantation

Marcel R M Van Den Brink · Kettering University · funded by National Institutes of Health

$486.8k

2018–2023 · research · R01

The role of bile acid metabolomics in graft-versus-host disease

Justin Cross · Kettering University · funded by National Institutes of Health

$584.5kGut microbiota and health

2018–2023 · grant · DP5

The role of chromosomal instability in tumor evolution

Samuel F Bakhoum · Kettering University · funded by National Institutes of Health

$449k

2018–2020 · career development · K99

Altered mRNA splicing dependent on mutant p53 identifies novel therapeutic vulnerability in pancreatic cancer

Luisa Escobar Hoyos · Kettering University · funded by National Institutes of Health

$102.1k

2018–2023 · research · R01

Ultrabright Theranostic SERRS Nanoparticles for Gastrointestinal Endoscopy

Moritz Florian Kircher · Kettering University · funded by National Institutes of Health

$716.9kSpectroscopy Techniques in Biomedical and Chemical Research

2018–2024 · grant · DP5

The role of chromosomal instability in tumor evolution

Samuel F Bakhoum · Kettering University · funded by National Institutes of Health

$449k

2018–2021 · research · R21

Accurate Determination of Dose to Mobile Organs at Risk in Hypofractionated Ablative Radiotherapy for Locally Advanced Pancreatic Cancer

Gikas S Mageras · Kettering University · funded by National Institutes of Health

$208.5kPancreatic and Hepatic Oncology Research

2018–2024 · research · R01

Development of optimal strategies to inhibit ERK signaling in tumors with RAF and MEK mutations

David B. Solit · Kettering University · funded by National Institutes of Health

$402.6kMelanoma and MAPK Pathways

2018–2023 · research · R01

Development of optimal strategies to inhibit ERK signaling in tumors with RAF and MEK mutations

David B. Solit · Kettering University · funded by National Institutes of Health

$398.5kMelanoma and MAPK Pathways

2018–2023 · cooperative agreement · U01

Pretargeted Clinical Imaging of CA19.9 in Pancreatic Cancer

Jason S. Lewis · Kettering University · funded by National Institutes of Health

$689.2k

2018–2024 · research · R01

Exploiting the distinct genomics and signaling of colorectal cancers to effectively target ERK

Rona Yaeger · Kettering University · funded by National Institutes of Health

$237.9kMelanoma and MAPK Pathways

2018–2021 · fellowship · F32

INVESTIGATING THE MOLECULAR BASIS OF OLAPARIB RESISTANCE IN BRCA2-DEFICIENT PROSTATE CANCER

Kyrie Jean Pappas · Kettering University · funded by National Institutes of Health

$67.6k

2018–2023 · program · P50

SPORE in Soft Tissue Sarcoma

Samuel Singer · Kettering University · funded by National Institutes of Health

$2.3MAdvanced Breast Cancer Therapies

2018–2023 · research · R01

Genetic Loss-of-Function Studies of SETD2 in Kidney Tumorigenesis

Emily H Cheng · Kettering University · funded by National Institutes of Health

$551.9kEpigenetics and DNA Methylation

2018–2023 · research · R01

Epigenetic mechanisms of transcriptional activation of a novel oncogenic ALK variant in cancer

Ping Chi · Kettering University · funded by National Institutes of Health

$497.8k

2018–2023 · research · R01

Endothelial cells regulate immune reconstitution after hematopoietic stem cell transplantation

Marcel R M Van Den Brink · Kettering University · funded by National Institutes of Health

$514.4k